Whilst at SfN’s Neuroscience 2017, Lauren Pulling sat down with Doris Doudet to hear more about her recent research, which has demonstrated elevated inflammation in the gut of a Parkinson’s disease rat model.
Browsing: Immune disorders and inflammation
This study measures severities of depression, anxiety and stress, and compares them to the used disease-modifying treatment.
Although exercise training has been advocated as a nonpharmacological treatment for multiple sclerosis-related fatigue, no consensus exists regarding its effectiveness.
Researchers have demonstrated significant reductions in levels of fatigue for multiple sclerosis patients in a randomized trial assessing transcranial direct current stimulation.
Novel research has suggested the gut microbiome is involved in multiple sclerosis and could be a treatment target.
Researchers from Japan have revealed a new neural pathway that links stress with organ dysfunction.
October babies are more likely to develop the syndrome, according to a study presented at the Congress of the European Academy of Neurology (Amsterdam, The Netherlands).
Researchers have found the first evidence that autoimmunity plays a role in Parkinson’s disease, showing that T cells recognize α-synuclein peptides.
Michael Pender discusses promising interim findings from a Phase 1 study investigating a novel treatment for multiple sclerosis.
Autoantibodies occur in many different nervous system disorders, and are increasingly being found in disorders not traditionally associated with the immune system. Determining if the autoantibodies play a functional or pathogenic role is critical in selecting the most appropriate treatment options.